Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 16.42%36.97M | 38.24%39.58M | 40.46%40.85M | 15.22%143.89M | 64.96%54.42M | 12.25%31.76M | -3.12%28.63M | -14.59%29.08M | 1.23%124.88M | 1.26%32.99M |
| Cost of revenue | 18.72%27.84M | 24.12%28.69M | 23.46%28.78M | 3.08%103.05M | 24.77%33.17M | 3.27%23.45M | -1.38%23.11M | -14.42%23.31M | 2.63%99.97M | 1.80%26.58M |
| Gross profit | 9.90%9.13M | 97.41%10.89M | 109.19%12.07M | 63.94%40.84M | 231.74%21.25M | 48.76%8.31M | -9.79%5.52M | -15.25%5.77M | -4.03%24.91M | -0.90%6.41M |
| Operating expense | 33.22%7.85M | 43.61%6.15M | 43.59%6.1M | 24.90%21.63M | 37.27%7.21M | 54.21%5.89M | 8.33%4.28M | -1.07%4.25M | -12.65%17.32M | -20.07%5.25M |
| Selling and administrative expenses | 38.92%8.27M | 38.03%6.3M | 40.41%6.38M | 22.12%22.67M | 37.49%7.57M | 45.08%5.95M | 1.76%4.57M | 1.66%4.54M | -9.77%18.56M | -11.62%5.51M |
| -Selling and marketing expense | 38.92%8.27M | 38.03%6.3M | 40.41%6.38M | 29.67%10.79M | 37.49%7.57M | 45.08%5.95M | 1.76%4.57M | 1.66%4.54M | -11.98%8.32M | 212.76%5.51M |
| -General and administrative expense | ---- | ---- | ---- | 15.97%11.87M | ---- | ---- | ---- | ---- | -7.88%10.24M | ---- |
| Total other operating income | 598.33%419K | -45.45%156K | -5.82%275K | -16.74%1.03M | 41.90%359K | -78.72%60K | -46.64%286K | 69.77%292K | 66.83%1.24M | 173.96%253K |
| Operating profit | -47.12%1.28M | 283.36%4.75M | 292.57%5.97M | 153.00%19.21M | 1,118.49%14.04M | 36.91%2.41M | -42.84%1.24M | -39.49%1.52M | 23.85%7.59M | 1,162.07%1.15M |
| Net non-operating interest income (expenses) | -300.00%-88K | -141.18%-82K | -57.14%-66K | 19.29%-131.8K | 2.86%-34K | 40.54%-22K | 17.07%-34K | 16.00%-42K | 44.40%-163.29K | 30.98%-35K |
| Non-operating interest expense | 300.00%88K | 141.18%82K | 57.14%66K | -19.29%131.8K | -2.86%34K | -40.54%22K | -17.07%34K | -16.00%42K | -44.40%163.29K | -30.98%35K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 177.78%7K | 0 | -126.12%-3.37K | 800.00%9K | 0 | -109.47%-9K | 96.10%-3K | -80.48%12.9K | 110.07%1K |
| Less:Write off | --0 | -177.78%-7K | --0 | 126.12%3.37K | -800.00%-9K | --0 | 109.47%9K | -96.10%3K | 80.48%-12.9K | -110.07%-1K |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -50.31%1.19M | 290.88%4.67M | 300.07%5.9M | 156.29%19.07M | 1,153.31%14.01M | 39.06%2.39M | -46.17%1.2M | -38.16%1.48M | 26.08%7.44M | 761.13%1.12M |
| Income tax | -61.26%399K | 211.37%1.59M | 213.09%1.99M | 116.65%6.47M | 577.92%4.3M | 42.27%1.03M | -29.36%510K | -30.10%634K | 1.37%2.99M | 55.84%634K |
| Net income | -42.02%788K | 350.07%3.08M | 365.64%3.92M | 182.88%12.6M | 1,907.02%9.71M | 36.72%1.36M | -54.27%685K | -43.10%841K | 50.72%4.45M | 184.04%484K |
| Net income continuous operations | -42.02%788K | 350.07%3.08M | 365.64%3.92M | 182.88%12.6M | 1,907.02%9.71M | 36.72%1.36M | -54.27%685K | -43.10%841K | 50.72%4.45M | 184.04%484K |
| Noncontrolling interests | -42.99%374K | 130.42%1.05M | 204.03%1.21M | 136.33%4.29M | 608.40%2.78M | 67.77%656K | 0.66%457K | -31.31%397K | -0.00%1.82M | 22.95%393K |
| Net income attributable to the company | -41.11%414K | 790.35%2.03M | 510.14%2.71M | 214.95%8.31M | 7,515.38%6.93M | 16.58%703K | -78.16%228K | -50.67%444K | 131.65%2.64M | 110.16%91K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -41.11%414K | 790.35%2.03M | 510.14%2.71M | 214.95%8.31M | 7,515.38%6.93M | 16.58%703K | -78.16%228K | -50.67%444K | 131.65%2.64M | 110.16%91K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -50.00%0.0005 | 866.67%0.0029 | 533.33%0.0038 | 216.22%0.0117 | 9,700.00%0.0098 | 11.11%0.001 | -78.57%0.0003 | -53.85%0.0006 | 131.39%0.0037 | 107.95%0.0001 |
| Diluted earnings per share | -50.00%0.0005 | 866.67%0.0029 | 533.33%0.0038 | 216.22%0.0117 | 9,700.00%0.0098 | 11.11%0.001 | -78.57%0.0003 | -53.85%0.0006 | 131.39%0.0037 | 107.95%0.0001 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.